Jelle Wesseling

Biography

Jelle Wesseling is consultant breast pathologist. He became Master of Science (MSc) in Medicine in 1987 and cum laude MSc in chemistry focusing on molecular and cell biology in 1991, both at the University of Groningen, the Netherlands. He received his PhD at the Netherlands Cancer Institute in 1997 under supervision of Prof. Dr. Piet Borst, Prof. Dr. Carl Figdor, and Dr. John Hilkens about the role of the carcinoma-associated mucin episialin (MUC1, CD227, EMA, CA15-3 antigen) in cell adhesion and tumor progression. He obtained his MD cum laude at the Free University in Amsterdam in 1999. He was trained as a pathologist at the University Medical Center Groningen for which he was registered in 2004. He returned to the NKI in 2006 where he became a consultant breast pathologist and group leader. He is member of various breast cancer working committees, both in the Netherlands as well as in Europe.  

Research Interest

His research focuses on optimizing personalized diagnosis and treatment of each breast cancer patient by searching for novel prognostic and predictive biomarkers using a combination of pathology, molecular analyses, and epidemiology. Ultimately, he aims at answering the questions which breast cancer patient needs what type of treatment for how much benefit.